Identification of threonine 422 in transmembrane domain αM4 of the nicotinic acetylcholine receptor as a possible site of interaction with hydrocortisone

Neuropharmacology

Volumn 43, Issue 1, 2002, Pages 65-73

  Garbus, Ingrid ^a   Roccamo, Ana M ^a   Barrantes, Francisco J ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

Cholinergic receptor; Glucocorticoid; Mutations; Patch clamp; Steroid

Indexed keywords

ACETYLCHOLINE; ALANINE; HYDROCORTISONE; NICOTINIC RECEPTOR; PROMEGESTONE; THREONINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROPHOBICITY; KINETICS; PATCH CLAMP; PHOTOAFFINITY LABELING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ACETYLCHOLINE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BINDING SITES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; HYDROCORTISONE; ION CHANNEL GATING; ION CHANNELS; MICE; MUTATION; PATCH-CLAMP TECHNIQUES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NICOTINIC; THREONINE;

EID: 0036629771     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00068-0     Document Type: Article

References (36)

1. Barrantes F.J. Structural-functional correlates of the nicotinic acetylcholine receptor and its lipid microenvironment. FASEB Journal. 7:1993;1460-1467.
2. Barrantes F.J. The Nicotinic Acetylcholine Receptor: Current Views and Future Trends. 1998;Springer Verlag, Berlin/Heidelberg and Landes Publishing Co, Georgetown, TX.
3. Barrantes F.J. Fluorescence studies of the acetylcholine receptor: Structure and dynamics in the membrane environment. Journal of Fluorescence. 11:2001;273-285.
4. Barrantes F.J., Antollini S.S., Bouzat C., Garbus I., Massol R.H. Nongenomic effects of steroids on the nicotinic acetylcholine receptor. Kidney International. 57:2000;1382-1389.
5. Barrantes F.J., Antollini S.S., Blanton M.P., Prieto M. Topography of nicotinic acetylcholine receptor membrane-embedded domains. Journal of Biological Chemistry. 275:2000;37333-37339.
6. Blanton M.P., Wang H.H. Localization of regions of the Torpedo californica nicotinic acetylcholine receptor labeled with an aryl azide derivative of phosphatidylserine. Biochemica Biophysica Acta. 1067:1991;1-8.
7. Blanton M.P., Cohen J.B. Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry. 31:1992;3738-3750.
8. Blanton M.P., Cohen J.B. Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: Secondary structure implications. Biochemistry. 33:1994;2859-2872.
9. Blanton M.P., Xie Y., Dangott L.J., Cohen J.B. The steroid promegestone, is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface. Molecular Pharmacology. 55:1999;269-278.
10. Bouzat C., Barrantes F.J. Acute exposure of nicotinic acetylcholine receptor to the synthetic glucocorticoid dexamethasone alters single channel gating properties. Molecular Neuropharmacology. 3:1993;109-116.
11. Bouzat C., Barrantes F.J. Hydrocortisone and 11-desoxycortisone modify acetylcholine receptor channel gating. NeuroReport. 4:1993;143-146.
12. Bouzat C., Bren N., Sine S. Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors. Neuron. 13:1994;1395-1402.
13. Bouzat C., Barrantes F.J. Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. Possible allosteric mechanism of channel blockade. Journal of Biological Chemistry. 271:1996;25835-25841.
14. Bouzat C., Roccamo A.M., Garbus I., Barrantes F.J. Mutations at lipid-exposed residues of the acetylcholine receptor affect its gating kinetics. Molecular Pharmacology. 54:1998;146-153.
15. Bouzat C., Barrantes F.J., Sine S. Nicotinic receptor fourth transmembrane domain: hydrogen bonding by conserved threonine contributes to channel gating kinetics. Journal of General Physiology. 115:2000;663-671.
16. Corbin J., Wang H.H., Blanton M.P. Identifying the cholesterol binding domain in the nicotinic acetylcholine receptor with [125l] azido-cholesterol. Biochimica Biophysica Acta. 1414:1998;65-74.
17. Criado M., Eibl H., Barrantes F.J. Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry. 21:1982;3622-3629.
18. Criado M., Eibl H., Barrantes F.J. Functional properties of the acetylcholine receptor incorporated in model lipid membranes. Differential effects of chain length and head group of phospholipids on receptor affinity states and receptor-mediated ion translocation. Journal of Biological Chemistry. 259:1984;9188-9198.
19. Franks N.P. Membrane spectroscopy. Grell E., Molecular Biology Biochemistry and Biophysics, vol 31. 1981;Springer-Verlag, Berlin.
20. Garbus I., Bouzat C.B., Barrantes F.J. Steroids differentially inhibit the nicotinic acetylcholine receptor. Neuroreport. 12:2001;227-231.
21. Giraudat J., Dennis M., Heidmann T., Chang J.-Y., Changeux J.P. Structure for the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: Serine 262 of the delta subunit is labeled by [3H] chlorpromazine. Proceedings of the National Academy of Science. 83:1986;22719-22723.
22. Giraudat J., Dennis M., Heidmann T., Haumont P.Y., Lederer F., Changeux J.P. Structure for the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H] chlorpromazine labels homologous residues in the beta and delta chains. Biochemistry. 26:1987;2410-2418.
23. Giraudat J., Galzi J.L., Revah F., Changeux J.P., Haumont P.Y., Lederer F. The noncompetitive blocker [3H] chlorpromazine labels segment M2 but not segment M1 of the nicotinic acetylcholine receptor α-subunit. FEBS Letters. 253:1989;190-198.
24. Hamill O.P., Marty A., Neher E., Sakmann E., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
25. Johnson N.L., Kotz S. Distribution in Statistics. 1969;Houghton-Mifflin, Boston.
26. Kindler C.H., Verotta D., Gray A.T., Gropper M.A., Yost C.S. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology. 92:2000;821-832.
27. Lasalde J.A., Tamamizu S., Butler D.H., Vibat C.R.T., Hung B., McNamee M.G. Tryptophan substitutions at the lipid-exposed transmembrane segment M4 of Torpedo californica acetylcholine receptor govern channel gating. Biochemistry. 35:1996;14139-14148.
28. Li L., Schuchard M., Palma A., Pradier L., McNamee M.G. Functional role of the cysteine 451 thiol group in the M4 helix of the gamma subunit of Torpedo californica acetylcholine receptor. Biochemistry. 29:1990;5428-5436.
29. Marsh D., Barrantes F.J. Immobilized lipid in acetylcholine receptor-rich membranes from Torpedo marmorata. Proceedings of the National Academy of Science USA. 75:1978;4329-4333.
30. Marsh D., Watts A., Barrantes F.J. Phospholipid chain immobilization and steroid rotational immobilization in acetylcholine receptor-rich membranes from Torpedo marmorata. Biochemica Biophysica Acta. 645:1981;97-101.
31. Ortells M.O., Barrantes G.E., Barrantes F.J. Molecular modeling of the nicotinic acetylcholine receptor. Barrantes F.J., The Nicotinic Acetylcholine Receptor: Current View and Future Trends, Neuroscience Intelligence Unit. 1998;Springer Verlag and Landes Publishing, Berlin and Austin, TX.
32. Sakmann B., Patlak J., Neher E. Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist. Nature. 286:1980;71-73.
33. Sigworth F., Sine S.M. Data transformations for improved display and fitting of single-channel dwell time histograms. Biophysical Journal. 52:1987;1047-1052.
34. Sine S.M. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity. Proceedings of the National Academy of Science USA. 90:1993;9436-9440.
35. Uki M., Nabekura J., Akaike N. Suppression of the nicotinic acetylcholine response in rat superior cervical ganglionic neurons by steroids. Journal of Neurochemistry. 72:1999;808-814.
36. Villalain J. Location of cholesterol in model membranes by magic-angle-sample-spinning NMR. European Journal of Biochemistry. 241:1996;586-593.